Published in Am J Pathol on May 01, 1989
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A (2000) 3.01
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood (2009) 2.92
Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood (2007) 2.37
No evidence for tissue factor on platelets. Blood (2010) 2.31
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30
Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol (1993) 2.27
Microparticles in hemostasis and thrombosis. Circ Res (2011) 2.26
Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest (1998) 2.19
Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood (2010) 2.10
Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Ann Thorac Surg (2014) 2.09
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem (2007) 2.01
P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A (1994) 2.00
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A (1999) 1.96
Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci U S A (1996) 1.93
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol (2004) 1.69
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev (2009) 1.62
Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care (2002) 1.59
Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest (1998) 1.58
Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids. Blood (2012) 1.57
Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest (1995) 1.52
The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med (2008) 1.51
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol (2000) 1.48
Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol (2011) 1.47
The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation (2009) 1.47
Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury. Blood (2015) 1.46
Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol (1993) 1.45
Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol (1994) 1.42
Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A (1990) 1.42
The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax (2007) 1.41
Science review: role of coagulation protease cascades in sepsis. Crit Care (2002) 1.37
Endothelium--role in regulation of coagulation and inflammation. Semin Immunopathol (2011) 1.37
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer (2000) 1.36
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol (1991) 1.36
Shear stress induction of the tissue factor gene. J Clin Invest (1997) 1.35
Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol (2009) 1.32
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A (2002) 1.31
The role of tissue factor and factor VIIa in hemostasis. Anesth Analg (2009) 1.31
Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure. Blood (2010) 1.29
Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol (2012) 1.29
Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation. Thromb Haemost (2014) 1.29
Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J (1995) 1.27
Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res (2011) 1.25
The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem (2010) 1.24
Cellular localization and trafficking of tissue factor. Blood (2006) 1.23
Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci U S A (2001) 1.22
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost (2009) 1.20
Tissue factor expression during human and mouse development. Am J Pathol (1996) 1.19
Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med (2004) 1.18
Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. Blood (2007) 1.18
Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc Natl Acad Sci U S A (2003) 1.17
Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci U S A (1997) 1.17
Tissue factor and thrombosis: The clot starts here. Thromb Haemost (2010) 1.16
Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol (2005) 1.14
Carbohydrates and activity of natural and recombinant tissue factor. J Biol Chem (2009) 1.13
Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest (1993) 1.12
Interplay between coagulation and vascular inflammation in sickle cell disease. Br J Haematol (2013) 1.12
Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res (2010) 1.09
Role of tissue factor in venous thrombosis. Annu Rev Physiol (2011) 1.09
The nature of the stable blood clot procoagulant activities. J Biol Chem (2008) 1.08
Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci U S A (1990) 1.08
Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun (1999) 1.08
Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality. J Clin Invest (2008) 1.07
Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.07
Protective mechanisms of activated protein C in severe inflammatory disorders. Br J Pharmacol (2009) 1.07
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest (1993) 1.05
Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res (2009) 1.04
Animal models of hemophilia. Prog Mol Biol Transl Sci (2012) 1.04
Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest (1993) 1.04
Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol (2006) 1.04
Immuno-PET of tissue factor in pancreatic cancer. J Nucl Med (2012) 1.02
Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans. J Thromb Haemost (2008) 1.02
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol (1995) 1.02
Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer (1999) 1.02
Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest (1999) 1.00
New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins. J Exp Med (2002) 1.00
Regulation of tissue factor coagulant activity on cell surfaces. J Thromb Haemost (2012) 0.99
Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth. Arterioscler Thromb Vasc Biol (2011) 0.99
The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis. Biochim Biophys Acta (2015) 0.99
Alternatively spliced isoforms of tissue factor pathway inhibitor. Thromb Res (2010) 0.98
Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest (1993) 0.98
Progestin and thrombin regulate tissue factor expression in human term decidual cells. J Clin Endocrinol Metab (2009) 0.98
The emerging role of neutrophils in thrombosis-the journey of TF through NETs. Front Immunol (2012) 0.98
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling. Blood (2007) 0.97
Side view thrombosis microfluidic device with controllable wall shear rate and transthrombus pressure gradient. Lab Chip (2013) 0.97
Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost (2007) 0.96
Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels. J Thromb Haemost (2014) 0.96
Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome. Curr Pharm Biotechnol (2011) 0.96
Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol (1993) 0.94
Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A (1992) 0.93
Traumatic brain injury-associated coagulopathy. J Neurotrauma (2012) 0.93
Venous thromboembolism in malignant gliomas. J Thromb Haemost (2009) 0.92
Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model. J Clin Invest (1991) 0.92
Cellular localization of thrombomodulin in human epithelium and squamous malignancies. Am J Pathol (1995) 0.92
Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice. Am J Pathol (2004) 0.91
Coagulation, protease-activated receptors, and viral myocarditis. J Cardiovasc Transl Res (2013) 0.91
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem (1979) 9.06
Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens. J Virol (1980) 7.51
Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med (1984) 5.89
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A (1986) 5.83
A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol (1977) 3.77
Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest (1983) 3.47
Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem (1981) 3.26
Tissue factor and hemostasis. Blood (1988) 3.15
Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab Invest (1988) 2.77
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood (1977) 2.30
The endotoxin-induced coagulant activity of human monocytes. Br J Haematol (1975) 2.27
Regulation of extravascular coagulation by microvascular permeability. Science (1985) 2.11
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res (1988) 2.00
Tissue factor revisited. Prog Hemost Thromb (1982) 1.86
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A (1987) 1.71
Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood (1983) 1.63
Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med (1981) 1.62
Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med (1983) 1.60
Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood (1979) 1.58
Hemostatic properties of normal and perturbed vascular cells. FASEB J (1988) 1.54
Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity. J Immunol (1982) 1.49
Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest (1984) 1.46
Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry (1987) 1.43
A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo. J Immunol (1981) 1.38
Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones. J Clin Invest (1985) 1.27
Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol (1986) 1.24
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. N Engl J Med (1980) 1.16
Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest (1988) 1.14
Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. Thromb Res (1988) 1.12
Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest (1983) 1.12
Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood (1988) 1.11
Cloning and expression of human tissue factor cDNA. Thromb Res (1987) 1.11
Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood (1988) 1.08
An alternative extrinsic pathway of human blood coagulation. Blood (1982) 1.02
Tissue factor activity of normal and neoplastic cells: quantitation and species specificity. J Natl Cancer Inst (1983) 0.99
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene (2006) 3.89
Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem (1979) 3.61
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
POLYCYSTIC KIDNEY. Ann Surg (1926) 2.38
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry (1989) 2.29
The structural biology of expression and function of tissue factor. Thromb Haemost (1991) 2.28
Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol (1988) 2.28
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med (1991) 2.10
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem (1980) 2.05
Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res (1988) 2.00
Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med (1980) 1.90
The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem (1988) 1.89
Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice. J Immunol (1977) 1.82
Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem (1982) 1.80
Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem (1991) 1.67
Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost (2007) 1.67
Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J Exp Med (1975) 1.66
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med (1981) 1.62
Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response. Crit Care Med (2001) 1.61
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol (1989) 1.61
The assessment by immunofluorescence methods of humoral anti-myelin antibodies in man. J Immunol (1970) 1.61
Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med (1983) 1.60
Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med (1975) 1.54
The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem (1991) 1.54
Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. J Clin Invest (1980) 1.53
Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med (1982) 1.53
Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J Immunol (1993) 1.52
A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release (2006) 1.51
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation (1999) 1.49
A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem (1990) 1.49
Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell (1992) 1.48
Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol (1976) 1.48
Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol (1989) 1.48
Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry (1995) 1.47
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. J Immunol (1971) 1.47
Properties of recombinant human thromboplastin that determine the International Sensitivity Index (ISI). J Thromb Haemost (2004) 1.46
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci U S A (1988) 1.44
Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol (1991) 1.44
Glomerular complement components in human glomerulonephritis. J Clin Invest (1974) 1.43
Rapid and efficient incorporation of tissue factor into liposomes. J Thromb Haemost (2004) 1.40
Defense. FASEB J (1994) 1.39
Polyphosphate as a general procoagulant agent. J Thromb Haemost (2008) 1.36
An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest (1975) 1.36
Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol (1986) 1.36
Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest (1981) 1.34
Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J (1994) 1.32
Differential synthesis of spore coat proteins in prespore and prestalk cells of Dictyostelium. Proc Natl Acad Sci U S A (1982) 1.32
Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP. J Exp Med (1974) 1.31
Dissociation of antibody from erythrocyte surfaces by chaotropic ions. J Immunol (1971) 1.31
A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol (1988) 1.31
The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide. J Immunol (1981) 1.31
Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. J Biol Chem (1994) 1.30
Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J (1991) 1.30
Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones. J Clin Invest (1985) 1.27
Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest (1979) 1.27
Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J (1995) 1.27
Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem (1992) 1.27
Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J Exp Med (1973) 1.26
Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation (1995) 1.25
Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Expr Purif (1992) 1.24
Factor-VIII-related antigen: multiple molecular forms in human plasma. Proc Natl Acad Sci U S A (1975) 1.24
Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J Clin Invest (1973) 1.24
The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J Mol Biol (1998) 1.24
Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity. J Exp Med (1984) 1.23
Intrahepatic expression of serum hepatitis virus-associated antigens. J Exp Med (1971) 1.22
Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway. J Exp Med (1981) 1.22
An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma. Thromb Haemost (1991) 1.19
Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest (1991) 1.16
Delineation of spontaneous erythrocyte autoantibody responses of NZB and other strains of mice. J Immunol (1978) 1.15
Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. Proc Natl Acad Sci U S A (1973) 1.15
Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract. N Engl J Med (1975) 1.14
Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. J Immunol (1986) 1.14
Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem (1992) 1.13
Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections. J Clin Invest (1976) 1.13
Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. J Immunol (1977) 1.12
Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. Thromb Res (1988) 1.12
Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J Biol Chem (1993) 1.11
Tissue factor positions and maintains the factor VIIa active site far above the membrane surface even in the absence of the factor VIIa Gla domain. A fluorescence resonance energy transfer study. J Biol Chem (1997) 1.10